471 related articles for article (PubMed ID: 11068599)
1. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
Dunst J
Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
[No Abstract] [Full Text] [Related]
2. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
3. [How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].
Lindner H
Strahlenther Onkol; 1998 Nov; 174(11):601-2. PubMed ID: 9830445
[No Abstract] [Full Text] [Related]
4. Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB; Naughton P; Walsh TN
Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
[TBL] [Abstract][Full Text] [Related]
5. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
Marnitz S; Köhler C; Roth C; Füller J; Bischoff A; Wendt T; Schneider A; Budach V
Strahlenther Onkol; 2007 Sep; 183(9):473-8. PubMed ID: 17762920
[TBL] [Abstract][Full Text] [Related]
6. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
7. Multimodal treatment of locally advanced cervical cancer.
Dueñas-González A; Cetina-Pérez L; Oñate-Ocaña LF; Rivera L; Lopez-Graniel C; González-Enciso A; Candelaria M; Mohar A
Arch Med Res; 2005; 36(2):129-35. PubMed ID: 15847945
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
10. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
12. [Clinical analysis of 215 elderly patients with cervical cancer].
Cheng M; Wu LY; Zhang WH; Huang MN; Zhang R
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):388-91. PubMed ID: 19799091
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Windschall A; Ott OJ; Sauer R; Strnad V
Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
[TBL] [Abstract][Full Text] [Related]
14. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
16. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ;
Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417
[TBL] [Abstract][Full Text] [Related]
17. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Hsueh S; Chen CK; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):429-36. PubMed ID: 20542643
[TBL] [Abstract][Full Text] [Related]
19. [Role of laparoscopy in the management of uterine cervix cancer].
Leblanc E; Querleu D; Castelain B; Occelli B; Chauvet MP; Chevalier A; Lesoin A; Vilain MO; Taieb S
Cancer Radiother; 2000; 4(2):113-21. PubMed ID: 10812356
[TBL] [Abstract][Full Text] [Related]
20. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
